World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
86533
World Ranking
10226
National Ranking
5259

Overview

Richard C. Mohs is affiliated with Eli Lilly in the United States and has contributed extensively to research in medicine, with a focus on dementia, cognitive impairment, and Alzheimer's disease. Their body of work spans various subfields including psychiatry and mental health, physiology, economics and econometrics, pharmacology, and neurology.

Their research primarily covers topics such as dementia and cognitive impairment research, Alzheimer's disease research and treatments, cholinesterase and neurodegenerative diseases, health systems, economic evaluations, quality of life, pharmaceutical economics and policy, statistical methods in clinical trials, and frailty in older adults.

Mohs has published in a range of scientific venues, with notable frequency in the following journals:

  • Alzheimer's & Dementia
  • Alzheimer's & Dementia Translational Research & Clinical Interventions
  • Journal of Alzheimer's Disease
  • Neurology
  • Nature Aging

Among the recent papers authored or co-authored by Mohs are:

  • The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer's disease (2024, Alzheimer's & Dementia)
  • The HOPE4MCI study: A randomized double-blind assessment of AGB101 for the treatment of MCI due to AD (2024, Alzheimer's & Dementia Translational Research & Clinical Interventions)
  • CERAD (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychology Assessment Battery: 35 Years and Counting (2023, Journal of Alzheimer's Disease)
  • Challenges and progress in research, diagnostics, and therapeutics in Alzheimer's disease and related dementias (2022, Alzheimer's & Dementia Translational Research & Clinical Interventions)
  • Value-Generating Exploratory Trials in Neurodegenerative Dementias (2021, Neurology)

Frequent collaborators in Mohs's work include John Dwyer, Jason Bork, Michela Gallagher, Douglas W. Beauregard, and Diana Kerwin, reflecting ongoing partnerships across multiple studies in the field.

Best Publications

  • The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

    Guy M. McKhann;Guy M. McKhann;David S. Knopman;Howard Chertkow;Bradley T. Hyman

  • Current concepts in mild cognitive impairment.

    Ronald C. Petersen;Rachelle Doody;Alexander Kurz;Richard C. Mohs

  • The consortium to establish a registry for alzheimer’s disease (CERAD). Part I. Clinical and neuropsychological assessment of alzheimer’s disease

    J. C. Morris;A. Heyman;R. C. Mohs;J. P. Hughes

  • A new rating scale for Alzheimer's disease.

    Wilma G. Rosen;Richard C. Mohs;Kenneth L. Davis

  • The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

    G.M. McKhann;D.S. Knopman;H. Chertkow;B.T. Hyman

  • A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

    S. L. Rogers;M. R. Farlow;R. S. Doody;R. Mohs

  • Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

    RS Rachelle S. Doody;RG Ronald G. Rg Thomas;Martin Farlow;Takeshi Iwatsubo

  • Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline

    Jan Näslund;Vahram Haroutunian;Richard Mohs;Kenneth L. Davis

  • Serotonergic Studies in Patients with Affective and Personality Disorders: Correlates with Suicidal and Impulsive Aggressive Behavior

    Emil F. Coccaro;Larry J. Siever;Howard M. Klar;Gail Maurer

  • A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

    Rachelle S. Doody;Rema Raman;Martin Farlow;Takeshi Iwatsubo

  • Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.

    Michael Grundman;Ronald C. Petersen;Steven H. Ferris;Ronald G. Thomas

  • The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery

    Kathleen A. Welsh;Nelson Butters;Richard C. Mohs;D. Beekly

  • Detection of Abnormal Memory Decline in Mild Cases of Alzheimer's Disease Using CERAD Neuropsychological Measures

    Kathleen Welsh;Nelson Butters;James Hughes;Richard Mohs

  • Donepezil Improves Cognition and Global Function in Alzheimer Disease A 15-Week, Double-blind, Placebo-Controlled Study

    Sharon L. Rogers;Rachelle S. Doody;Richard C. Mohs;Lawrence T. Friedhoff

  • Development of cognitive instruments for use in clinical trials of antidementia drugs: Additions to the Alzheimer's Disease Assessment Scale that broaden its scope.

    Richard C. Mohs;David Knopman;Ronald C. Petersen;Steven H. Ferris

  • High, usual and impaired functioning in community-dwelling older men and women: Findings from the MacArthur Foundation Research Network on successful aging

    Lisa F. Berkman;Teresa E. Seeman;Marilyn Albert;Dan Blazer

  • Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease

    Kathleen A. Welsh;Nelson Butters;James P. Hughes;Richard C. Mohs

  • Cholinergic markers in elderly patients with early signs of Alzheimer disease.

    Kenneth L. Davis;Richard C. Mohs;Deborah Marin;Dushyant P. Purohit

  • A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

    Richard C. Mohs;R. S. Doody;J. C. Morris;J. R. Ieni

  • The Consortium to Establish a Registry for Alzheimer's Disease (CERAD).: Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years

    D. Galasko;S.D. Edland;J. C. Morris;C. Clark

Frequent Co-Authors

Kenneth L. Davis
Kenneth L. Davis Icahn School of Medicine at Mount Sinai
Jeremy M. Silverman
Jeremy M. Silverman Icahn School of Medicine at Mount Sinai
Philip D. Harvey
Philip D. Harvey University of Miami
Larry J. Siever
Larry J. Siever Icahn School of Medicine at Mount Sinai
Richard S.E. Keefe
Richard S.E. Keefe Duke University
Paul S. Aisen
Paul S. Aisen University of Southern California
Vahram Haroutunian
Vahram Haroutunian Icahn School of Medicine at Mount Sinai
Michael H. Davidson
Michael H. Davidson University of Chicago
James Schmeidler
James Schmeidler Icahn School of Medicine at Mount Sinai
Rachelle S. Doody
Rachelle S. Doody Roche (Switzerland)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring career options related to medicine, there are several in-demand online health degrees that offer flexibility and affordability. Earning a graduate degree in healthcare is a powerful way to expand your professional opportunities, whether you are interested in clinical practice, healthcare leadership, or specialized roles.

For those inclined toward management, the cheapest online master degree in healthcare administration can help you move into key administrative positions at hospitals and clinics. If your goal is advanced clinical practice, consider cheap online dnp programs, which focus on developing clinical leadership and nurse practitioner skills.

Pharmacists are also in high demand, and the best online pharmacy school options allow you to earn your PharmD with greater convenience. If you’re interested in the technology side of health, online rhit degree programs prepare you for roles in managing electronic health data.

Online degrees in healthcare are becoming more reputable and affordable, making it easier for students to chart specialized career pathways that align with their interests and professional goals.

Best Scientists Citing Richard C. Mohs

Trending Scientists